Niedrigmaligne B-Zell-Lymphome

  • Hans Konrad Müller-Hermelink
  • German Ott
Part of the Molekulare Medizin book series (MOLMED)


Die Geschichte der Klassifikation maligner Tumoren des lymphatischen Systems ist lange, kontrovers und kompliziert. 1832 beschrieb Sir Thomas Hodgkin zuerst maligne Tumoren in Lymphknoten. Der Begriff der „Leukämie“folgte 1845 durch Virchow, der 1863 auch das Lymphosarkom und das Lymphom definierte. Um die Jahrhundertwende beschrieben Sternberg und Reed, 1898 und 1902, die Morphologie der Tumorzellen des Morbus Hodgkin. 25 Jahre später definierten Brill und Symmers das follikuläre Lymphom, und 1948 beschrieben Burkitt und 1960 O’Connor und Davis das endemische Burkitt-Lymphom in Afrika. In diesem sehr kurzen Überblick sind allerdings nur die historischen „Meilensteine“erwähnt, die auch heute, am Beginn des 21. Jahrhunderts, noch von Bedeutung sind.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aalto Y, Nordling S, Kivioja AH, Karaharju E, Elomaa I, Knuutila S (1999) Among numerous DNA copy number changes, losses of chromosome 13 are highly recurrent in plasmacytoma. Genes Chromosomes Cancer 25:104–107PubMedCrossRefGoogle Scholar
  2. Akiyama N, Tsuruta H, Sasaki H et al. (1994) Messenger RNA levels of five genes located at chromosome 11q13 in B-cell tumors with chromosome translocation t(11;14)(q13;q32). Cancer Res 54:377–379PubMedGoogle Scholar
  3. Alpen B, Neubauer A, Dierlamm J et al. (2000) Translocation t(11;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection. Blood 95:4014–4015PubMedGoogle Scholar
  4. Anderson T, Bender RA, Fisher RI et al. (1977) Combination chemotherapy in non-Hodgkin’s lymphoma: results of long-term followup. Cancer Treat Rep 61:1057–1066PubMedGoogle Scholar
  5. Ando K, Ajchenbaum-Cymbalista F, Griffin JD (1993) Regulation of G1/S transition by cyclins D2 and D3 in hematopoietic cells. Proc Natl Acad Sci USA 90:9571–9575PubMedCrossRefGoogle Scholar
  6. Ankathil R, Madhavan J, Gangadharan VP, Pillai GR, Nair MK (1995) Nonrandom karyotype abnormalities in 36 multiple myeloma patients. Cancer Genet Cytogenet 83:71–74PubMedCrossRefGoogle Scholar
  7. Arber N, Doki Y, Han EK et al. (1997) Antisense to cyclin Dl inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res 57:1569–1574PubMedGoogle Scholar
  8. Ashkenazi A,Dixit VM (1998) Death receptors: signaling and modulation. Science 281:1305–1308PubMedCrossRefGoogle Scholar
  9. Audouin J, Diebold J, Schvartz H, Le Tourneau A, Bernadou A, Zittoun R (1988) Malignant lymphoplasmacytic lymphoma with prominent splenomegaly (primary lymphoma of the spleen). J Pathol 155:17–33PubMedCrossRefGoogle Scholar
  10. Auer I A, Gascoyne RD, Connors JM et al. (1997) t(11;18)(q21;q21) is the most common translocation in MALT lymphomas. Ann Oncol 8:979–985PubMedCrossRefGoogle Scholar
  11. Baens M, Maes B, Steyls A, Geboes K, Marynen P, De Wolf-Peeters C (2000) The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation. Am J Pathol 156:1433–1439PubMedCrossRefGoogle Scholar
  12. Bakhshi A, Jensen JP, Goldman P et al. (1985) Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 41:899–906PubMedCrossRefGoogle Scholar
  13. Bakkus MH, Van Riet I, Van Camp B, Thielemans K (1994) Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell. Br J Haematol 87:68–74PubMedCrossRefGoogle Scholar
  14. Baldini L, Fracchiolla NS, Cro LM et al. (1994) Frequent p53 gene involvement in splenic B-cell leukemia/lymphomas of possible marginal zone origin. Blood 84:270–278PubMedGoogle Scholar
  15. Baldini L, Guffanti A, Cro L et al. (1997) Poor prognosis in non-villous splenic marginal zone cell lymphoma is associated with p53 mutations. Br J Haematol 99:375–378PubMedCrossRefGoogle Scholar
  16. Banks PM, Chan J, Cleary ML et al. (1992) Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 16:637–640PubMedCrossRefGoogle Scholar
  17. Bartl R, Frisch B, Burkhardt R et al. (1982) Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and staging. Br J Haematol 51:361–375PubMedCrossRefGoogle Scholar
  18. Basilico C, Moscatelli D (1993) The FGF family of growth factors and oncogens. Adv Cancer Res 60:1–165Google Scholar
  19. Bataille R (1982) Localized plasmacytomas. Clin Haematol 11:113–122PubMedGoogle Scholar
  20. Bayerdorffer E, Neubauer A, Rudolph B et al. (1995) Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 345:1591–1594PubMedCrossRefGoogle Scholar
  21. Bentz M, Plesch A, Bullinger L et al. (2000) t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer 27:285–294PubMedCrossRefGoogle Scholar
  22. Berard CW (1975) The reticuloendothelial system: an overview of neoplasia. In: Rebuck JW, Berard CW, Abell MR (eds) The reticuloendothelial system. Williams & Wilkins, Baltimore, pp 301–317Google Scholar
  23. Bergsagel PL, Chesi M, Nardini E, Brents LA, Kirby SL, Kuehl WM (1996) Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. Proc Natl Acad Sci USA 93:13.931–13.936Google Scholar
  24. Bernstein L, Newton P, Ross RK (1990) Epidemiology of hairy cell leukemia in Los Angeles County. Cancer Res 50:3605–3609PubMedGoogle Scholar
  25. Bertoni F, Cazzaniga G, Bosshard G et al. (1997) Immunoglobulin heavy chain diversity genes rearrangement pattern indicates that MALT-type gastric lymphoma B cells have undergone an antigen selection process. Br J Haematol 97:830–836PubMedCrossRefGoogle Scholar
  26. Bitter MA (1992) In: Knowles DM (ed) Neoplastic hematopathology. William & Wilkins. Baltimore, pp 1209–1234Google Scholar
  27. Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM (1994) Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J 13:2124–2130PubMedGoogle Scholar
  28. Bosch F, Campo E, Jares P et al. (1995) Increased expression of the PRAD-1/CCND1 gene in hairy cell leukaemia. Br J Haematol 91:1025–1030PubMedCrossRefGoogle Scholar
  29. Bouroncle BA (1979) Leukemic reticuloendotheliosis (hairy cell leukemia). Blood 53:412–436PubMedGoogle Scholar
  30. Brill NE, Baehr G, Rosenthal N (1925) Generalized giant lymph follicle hyperplasia of lymph nodes and slpeen. A hitherto undescribed type. JAMA 84:668–671Google Scholar
  31. Brito-Babapulle V, Pittman S, Melo JV, Pomfret M, Catovsky D (1987) Cytogenetic studies on prolymphocytic leukemia. 1. B-cell prolymphocytic leukemia. Hematol Pathol 1:27–33PubMedGoogle Scholar
  32. Brito-Babapulle V, Ellis J, Matutes E et al. (1992) Translocation t(11;14)(q13;q32) in chronic lymphoid disorders. Genes Chromosomes Cancer 5:158–165PubMedCrossRefGoogle Scholar
  33. Brittinger G, Bartels H, Common H et al. (1984) Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group. Hematol Oncol 2:269–306PubMedGoogle Scholar
  34. Brynes RK, Almaguer PD, Leathery KE et al. (1996) Numeri- cal cytogenetic abnormalities of chromosomes 3, 7, and 12 in marginal zone B-cell lymphomas. Mod Pathol 9:995–1000PubMedGoogle Scholar
  35. Burke JS (1978) The value of the bone-marrow biopsy in the diagnosis of hairy cell leukemia. Am J Clin Pathol 70:876–884PubMedGoogle Scholar
  36. Burke JS, Rappaport H (1984) The diagnosis and differential diagnosis of hairy cell leukemia in bone marrow and spleen. Semin Oncol 11:334–346PubMedGoogle Scholar
  37. Burke JS, Sheibani K (1987) Hairy cells and monocytoid B lymphocytes: are they related? Leukemia 1:298–300PubMedGoogle Scholar
  38. Busslinger M, Nutt SL (1998) Molecular Biology of B-cell and T-cell development. Humana Totowa, NJ, Monroe GEV, Rotheberg, pp 83–110Google Scholar
  39. Busslinger M, Klix N, Pfeffer P, Graninger PG, Kozmik Z (1996) Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large- cell lymphoma. Proc Natl Acad Sci USA 93:6129–6134PubMedCrossRefGoogle Scholar
  40. Calasanz MJ, Cigudosa JC, Odero MD et al. (1997) Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations. Genes Chromosomes Cancer 18:84–93PubMedCrossRefGoogle Scholar
  41. Campo E, Miquel R, Krenacs L, Sorbara L, Raffeld M, Jaffe ES (1999) Primary nodal marginal zone lymphomas of splenic and MALT type. Am J Surg Pathol 23:59–68PubMedCrossRefGoogle Scholar
  42. Catovsky D (1977) Hairy-cell leukaemia and prolymphocytic leukaemia. Clin Haematol 6:245–268PubMedGoogle Scholar
  43. Catovsky D (1990) Prolymphocytic and hairy cell leukemia. In: Henderson ES, Lister TA (eds) Leukemia. Saunders, Philadelphia, pp 639–660Google Scholar
  44. Chan JK (1996) Gastrointestinal lymphomas: an overview with emphasis on new findings and diagnostic problems. Semin Diagn Pathol 13:260–296PubMedGoogle Scholar
  45. Chan JK, Ng CS, Isaacson PG (1990) Relationship between high-grade lymphoma and low-grade B-cell mucosa-associated lymphoid tissue lymphoma (MALToma) of the stomach. Am J Pathol 136:1153–1164PubMedGoogle Scholar
  46. Chesi M, Bergsagel PL, Brents LA, Smith CM, Gerhard DS, Kuehl WM (1996) Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. Blood 88:674–681PubMedGoogle Scholar
  47. Chesi M, Nardini E, Brents LA (1997) Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet 16:260–264PubMedCrossRefGoogle Scholar
  48. Chesi M, Bergsagel PL, Shonukan OO et al. (1998a) Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. Blood 91:4457–4463PubMedGoogle Scholar
  49. Chesi M, Nardini E, Lim RS, Smith KD, Kuehl WM, Bergsagel PL (1998b) The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts. Blood 92:3025–3034PubMedGoogle Scholar
  50. Cleary ML, Sklar J (1985) Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 82:7439–7443PubMedCrossRefGoogle Scholar
  51. Cleary ML, Galili N, Sklar J (1986) Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas. J Exp Med 164:315–320PubMedCrossRefGoogle Scholar
  52. Cogliatti SB, Lennert K, Hansmann ML, Zwingers TL (1990) Monocytoid B cell lymphoma: clinical and prognostic features of 21 patients. J Clin Pathol 43:619–625PubMedCrossRefGoogle Scholar
  53. Corcoran MM, Mould S J, Orchard JA et al. (1999) Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations. Oncogene 18:6271–6277PubMedCrossRefGoogle Scholar
  54. Corradini P, Inghirami G, Astolfi M et al. (1994) Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias. Leukemia 8:758–767PubMedGoogle Scholar
  55. Cousar JB, McGinn DL, Glick AD, List AF, Collins RD (1987) Report of an unusual lymphoma arising from parafollicular B-lymphocytes (PBLs) or so-called „monocytoid“lymphocytes. Am J Clin Pathol 87:121–128PubMedGoogle Scholar
  56. Dallenbach FE, Coupland SE, Stein H (2000) Marginal zone lymphomas: extranodal MALT type, nodal and splenic. Pathologe 21:162–177PubMedCrossRefGoogle Scholar
  57. Dao DD, Sawyer JR, Epstein J, Hoover RG, Barlogie B, Tricot G (1994) Deletion of the retinoblastoma gene in multiple myeloma. Leukemia 8:1280–1284PubMedGoogle Scholar
  58. Davi F, Maloum K, Michel A et al. (1996) High frequency of somatic mutations in the VH genes expressed in prolymphocytic leukemia. Blood 88:3953–3961PubMedGoogle Scholar
  59. De Boer CJ, Schuuring E, Dreef E et al. (1995) Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood 86:2715–2723PubMedGoogle Scholar
  60. De Boer CJ, van Krieken JH, Kluin-Nelemans HC, Kluin PM, Schuuring E (1995) Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma. Oncogene 10:1833–1840PubMedGoogle Scholar
  61. De Jong D, Boot H, van Heerde P, Hart G A, Taal BG (1997) Histological grading in gastric lymphoma: pretreatment criteria and clinical relevance. Gastroenterology 112:1466–1474PubMedCrossRefGoogle Scholar
  62. De Jong D, Voetdijk BM, Beverstock GC, van Ommen GJ, Willemze R, Kluin PM (1988) Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma. N Engl J Med 318:1373–1378PubMedCrossRefGoogle Scholar
  63. Deveraux QL, Reed JC (1999) IAP family proteins — suppressors of apoptosis. Genes Dev 13:239–252PubMedCrossRefGoogle Scholar
  64. Dierlamm J, Michaux L, Wlodarska I et al. (1996 a) Trisomy 3 in marginal zone B-cell lymphoma: a study based on cytogenetic analysis and fluorescence in situ hybridization. Br J Haematol 93:242–249PubMedCrossRefGoogle Scholar
  65. Dierlamm J, Pittaluga S, Wlodarska I et al. (1996 b) Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features. Blood 87:299–307PubMedGoogle Scholar
  66. Dierlamm J, Pittaluga S, Stul M et al. (1997) BCL6 gene rearrangements also occur in marginal zone B-cell lymphoma. Br J Haematol 98:719–725PubMedCrossRefGoogle Scholar
  67. Dierlamm J, Baens M, Wlodarska I et al. (1999) The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 93:3601–3609PubMedGoogle Scholar
  68. Dierlamm J, Stefanova M, Wlodarska I et al. (2000) Analysis of the P53, RB/D13S25, and P16 tumor suppressor genes in marginal zone B-cell lymphoma: an interphase fluorescence in situ hybridization study. Cancer Genet Cytogenet 120:1–5PubMedCrossRefGoogle Scholar
  69. Dogan A, Du MQ, Aiello A et al. (1998) Follicular lymphomas contain a clonally linked but phenotypically distinct neoplastic B-cell population in the interfollicular zone. Blood 91:4708–4714PubMedGoogle Scholar
  70. Drach J, Ackermann J, Fritz E et al. (1998) Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy. Blood 92:802–809PubMedGoogle Scholar
  71. Dreyling MH, Bullinger L, Ott G et al. (1997) Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma. Cancer Res 57:4608–4614PubMedGoogle Scholar
  72. Dreyling MH, Roulston D, Bohlander SK, Vardiman J, Olopade OI (1998) Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin’s lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma. Genes Chromosomes Cancer 22:72–78PubMedCrossRefGoogle Scholar
  73. Du M, Peng H, Singh N, Isaacson PG, Pan L (1995) The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma. Blood 86:4587–4593PubMedGoogle Scholar
  74. Du M, Diss TC, Xu C, Peng H, Isaacson PG, Pan L (1996) Ongoing mutation in MALT lymphoma immunoglobulin gene suggests that antigen stimulation plays a role in the clonal expansion. Leukemia 10:1190–1197PubMedGoogle Scholar
  75. Du MQ, Peng H, Liu H et al. (2000) BCL10 gene mutation in lymphoma. Blood 95:3885–3890PubMedGoogle Scholar
  76. Elenitoba-Johnson KS, Gascoyne RD, Lim MS, Chhanabai M, Jaffe ES, Raffeid M (1998) Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma. Blood 91:4677–4685PubMedGoogle Scholar
  77. Fakruddin JM, Chaganti RS, Murty VV (1999) Lack of BCL10 mutations in germ cell tumors and B cell lymphomas. Cell 97:683–688PubMedCrossRefGoogle Scholar
  78. Falini B, Pileri SA, Flenghi L et al. (1990) Selection of a panel of monoclonal antibodies for monitoring residual disease in peripheral blood and bone marrow of interferon-treated hairy cell leukaemia patients. Br J Haematol 76:460–468PubMedCrossRefGoogle Scholar
  79. Feinman R, Sawyer J, Hardin J, Tricot G (1997) In: Barlogie B (ed) Hematology/oncology. Clinics of North America: multiple myeloma. Saunders, Philadelphia, pp 1Google Scholar
  80. Fisher RI, Dahlberg S, Nathwani BN, Banks PM, Miller TP, Grogan TM (1995) A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study. Blood 85:1075–1082PubMedGoogle Scholar
  81. Flandrin G, Sigaux F, Sebahoun G, Bouffette P (1984) Hairy cell leukemia: clinical presentation and follow-up of 211 patients. Semin Oncol 11:458–471PubMedGoogle Scholar
  82. Fujimoto M, Poe JC, Inaoki M, Tedder TF (1998) CD19 regulates B lymphocyte responses to transmembrane signals. Semin Immunol 10:267–277PubMedCrossRefGoogle Scholar
  83. Gall EA, Morrison HR, Scott AT (1941) The follicular type of malignant lymphoma: a survey of 63 cases. Ann Intern Med 14:2073–2090Google Scholar
  84. Galton DA, Goldman JM, Wiltshaw E, Catovsky D, Henry K, Goldenberg GJ (1974) Prolymphocytic leukaemia. Br J Haematol 27:7–23PubMedCrossRefGoogle Scholar
  85. Garcia-Marco JA, Nouel A, Navarro B et al. (1998) Molecular cytogenetic analysis in splenic lymphoma with villous lymphocytes: frequent allelic imbalance of the RB1 gene but not the D13S25 locus on chromosome 13q14. Cancer Res 58:1736–1740PubMedGoogle Scholar
  86. Gauwerky CE, Haluska FG, Tsujimoto Y, Nowell PC, Croce CM (1988) Evolution of B-cell malignancy: pre-B-cell leukemia resulting from MYC activation in a B-cell neoplasm with a rearranged BCL2 gene. Proc Natl Acad Sci USA 85:8548–8552PubMedCrossRefGoogle Scholar
  87. Glick JH, McFadden E, Costello W, Ezdinli E, Berard CW, Bennett JM (1982) Nodular histiocytic lymphoma: factors influencing prognosis and implications for aggressive chemotherapy. Cancer 49:840–845PubMedCrossRefGoogle Scholar
  88. Golomb HM (1978) Hairy cell leukemia: an unusual lymphoproliferative disease: a study of 24 patients. Cancer 42:946–956PubMedCrossRefGoogle Scholar
  89. Golomb HM, Vardiman JW (1983) Response to splenectomy in 65 patients with hairy cell leukemia: an evaluation of spleen weight and bone marrow involvement. Blood 61:349–352PubMedGoogle Scholar
  90. Golomb HM, Lindgren V, Rowley JD (1978) Chromosome abnormalities in patients with hairy cell leukemia. Cancer 41:1374–1380PubMedCrossRefGoogle Scholar
  91. Green DR (1998) Apoptotic pathways: the roads to ruin. Cell 94:695–698PubMedCrossRefGoogle Scholar
  92. Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281:1309–1312PubMedCrossRefGoogle Scholar
  93. Greiner A, Marx A, Heesemann J, Leebmann J, Schmausser B, Muller-Hermelink HK (1994) Idiotype identity in a MALT-type lymphoma and B cells in Helicobacter pylori associated chronic gastritis. Lab Invest 70:572–578PubMedGoogle Scholar
  94. Greiner TC, Moynihan MJ, Chan WC et al. (1996) p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood 87:4302–4310PubMedGoogle Scholar
  95. Greiner A, Seeberger H, Knorr C, Muller-Hermelink HK (1999) [MALT-type B-cell lymphomas escape fasmediated apoptosis]. Verh Dtsch Ges Pathol 83:247–253PubMedGoogle Scholar
  96. Greipp PR, Raymond NM, Kyle RA, O’Fallon WM (1985) Multiple myeloma: significance of plasmablastic subtype in morphological classification. Blood 65:305–310PubMedGoogle Scholar
  97. Grogan TM, Spier CM (1992) The B cell immunoproliferative disorders; including multiple myeloma and amylpoidosis. In: Knowles DM (ed) Neoplastic haematopathology. William & Wilkins, BaltimoreGoogle Scholar
  98. Gronbaek K, Straten PT, Ralfkiaer E et al. (1998) Somatic Fas mutations in non-Hodgkin’s lymphoma: association with extranodal disease and autoimmunity. Blood 92:3018–3024PubMedGoogle Scholar
  99. Gruszka-Westwood AM, Matutes E, Coignet LJ, Wotherspoon A, Catovsky D (1999) The incidence of trisomy 3 in splenic lymphoma with villous lymphocytes: a study by FISH. Br J Haematol 104:600–604PubMedCrossRefGoogle Scholar
  100. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70PubMedCrossRefGoogle Scholar
  101. Harada H, Fujita T, Miyamoto M et al. (1989) Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58:729–739PubMedCrossRefGoogle Scholar
  102. Harris CC (1996) p53 tumor suppressor gene: from the basic research laboratory to the clinic — an abridged historical perspective. Carcinogenesis 17:1187–1198PubMedCrossRefGoogle Scholar
  103. Harris NL, Bhan AK (1985) B-cell neoplasms of the lymphocytic, lymphoplasmacytoid, and plasma cell types: immunohistologic analysis and clinical correlation. Hum Pathol 16:829–837PubMedCrossRefGoogle Scholar
  104. Harris NL, Ferry (1992) Folliucular lymphoma and related dirorders (germainl center lymphomas. In: Knowles DM (ed) Neoplastic haematopathology. William & Wilkins, Baltimore, pp 645–674Google Scholar
  105. Harris NL, Jaffe ES, Stein H et al. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361–1392PubMedGoogle Scholar
  106. Harris NL, Jaffe ES, Diebold J et al. (1999) The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November 1997. Ann Oncol 10:1419–1432PubMedCrossRefGoogle Scholar
  107. Hatzivassiliou G, Iida S, Rao PH et al. (1998) Two novel genes related to the Fc receptor family involved in the t(1;14)(q21;q32) chromosomal translocation in multiple myeloma. Blood 92:509aGoogle Scholar
  108. Heim S, Mitelman F (1995) Cancer cytogenetics. Wiley-Liss, New YorkGoogle Scholar
  109. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ (1990) BCL2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334–336PubMedCrossRefGoogle Scholar
  110. Hoeve MA, Ferreira Mota SC, Schuuring E et al. (1999 a) Frequent allelic imbalance but infrequent microsatellite instability in gastric lymphoma. Leukemia 13:1804–1811PubMedCrossRefGoogle Scholar
  111. Hoeve MA, Gisbertz IA, Schouten HC et al. (1999 b) Gastric low-grade MALT lymphoma, high-grade MALT lymphoma and diffuse large B cell lymphoma show different frequencies of trisomy. Leukemia 13:799–807PubMedCrossRefGoogle Scholar
  112. Hollema H, Poppema S (1988) Immunophenotypes of malignant lymphoma centroblastic-centrocytic and malignant lymphoma centrocytic: an immunohistologic study indicating a derivation from different stages of B cell differentiation. Hum Pathol 19:1053–1059PubMedCrossRefGoogle Scholar
  113. Hummel M, Tamaru J, Kalvelage B, Stein H (1994) Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood 84:403–407PubMedGoogle Scholar
  114. Hussell T, Isaacson PG, Spencer J (1993) Proliferation and differentiation of tumour cells from B-cell lymphoma of mucosa-associated lymphoid tissue in vitro. J Pathol 169:221–227PubMedCrossRefGoogle Scholar
  115. Hussell T, Isaacson PG, Crabtree JE, Spencer J (1996) Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J Pathol 178:122–127PubMedCrossRefGoogle Scholar
  116. Iida S, Rao PH, Nallasivam P et al. (1996) The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. Blood 88:4110–4117PubMedGoogle Scholar
  117. Iida S, Rao PH, Butler M et al. (1997) Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nat Genet 17:226–230PubMedCrossRefGoogle Scholar
  118. Inaba T, Matsushime H, Valentine M, Roussel MF, Sherr CJ, Look AT (1992) Genomic organization, chromosomal localization, and independent expression of human cyclin D genes. Genomics 13:565–574PubMedCrossRefGoogle Scholar
  119. Isaacson PWD (1983) Malignant lymphoma of mucosa-associated lymphoid tissue: a distinctive type of B cell lymphoma. Cancer 52:1410–1416PubMedCrossRefGoogle Scholar
  120. Isaacson PG (1999) Gastric MALT lymphoma: from concept to cure. Ann Oncol 10:637–645PubMedCrossRefGoogle Scholar
  121. Isaacson PG, Norton AJ (1994) Extranodal lymphomas. Churchill Livingstone, Edinburgh London New YorkGoogle Scholar
  122. Isaacson PG, MacLennan KA, Subbuswamy SG (1984) Multiple lymphomatous polyposis of the gastrointestinal tract. Histopathology 8:641–656PubMedCrossRefGoogle Scholar
  123. Isaacson PG, Matutes E, Burke M, Catovsky D (1994) The histopathology of splenic lymphoma with villous lymphocytes. Blood 84:3828–3834PubMedGoogle Scholar
  124. Jadayel D, Matutes E, Dyer MJ et al. (1994) Splenic lymphoma with villous lymphocytes: analysis of BCL1 rearrangements and expression of the cyclin D1 gene. Blood 83:3664–3671PubMedGoogle Scholar
  125. Jaeger U, Purtscher B, Karth GD, Knapp S, Mannhalter C, Lechner K (1993) Mechanism of the chromosomal translocation t(14;18) in lymphoma: detection of a 45-Kd breakpoint binding protein. Blood 81:1833–1840PubMedGoogle Scholar
  126. Jaffe ES, Braylan RC, Nanba K, Frank MM, Berard CW (1977) Functional markers: a new perspective on malignant lymphomas. Cancer Treat Rep 61:953–962PubMedGoogle Scholar
  127. Jaffe ES, Bookman MA, Longo DL (1987) Lymphocytic lymphoma of intermediate differentiation — mantle zone lymphoma: a distinct subtype of B-cell lymphoma. Hum Pathol 18:877–880PubMedCrossRefGoogle Scholar
  128. Jansen J, Hermans J (1982) Clinical staging system for hairy-cell leukemia. Blood 60:571–577PubMedGoogle Scholar
  129. Johansson B, Mertens F, Mitelman F (1995) Cytogenetic evolution patterns in non-Hodgkin’s lymphoma. Blood 86:3905–3914PubMedGoogle Scholar
  130. Jones SE (1973) Autoimmune disorders and malignant lymphoma. Cancer 31:1092–1098PubMedCrossRefGoogle Scholar
  131. Juge-Morineau N, Mellerin MP, Francois S et al. (1995) High incidence of deletions but infrequent inactivation of the retinoblastoma gene in human myeloma cells. Br J Haematol 91:664–667PubMedCrossRefGoogle Scholar
  132. Kalla J, Stilgenbauer S, Schaffner C et al. (2000) Heterogeneity of the API2-MALT1 gene rearrangement in MALT-type lymphoma. Leukemia 14:1967–1974PubMedCrossRefGoogle Scholar
  133. Kapadia SB, Desai U, Cheng VS (1982) Extramedullar plasmacytoma of the head and neck. A clinicopathologic study of 20 cases. Medicine (Baltimore) 61:317–329Google Scholar
  134. Kataoka K, Nishizawa M, Kawai S (1993) Structure-function analysis of the maf oncogene product, a member of the b-Zip protein family. J Virol 67:2133–2141PubMedGoogle Scholar
  135. Katzenberger T, Lohr A, Ott MM et al. (2000) Genetische und biologische Unterschiede definieren zwei Varianten follikulärer Non-Hodgkin-Lymphome Grad 3. Verh Dtsch Ges PatholGoogle Scholar
  136. Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239–257PubMedCrossRefGoogle Scholar
  137. Kluin-Nelemans HC, Beverstock GC, Mollevanger P et al. (1994) Proliferation and cytogenetic analysis of hairy cell leukemia upon stimulation via the CD40 antigen. Blood 84:3134–3141PubMedGoogle Scholar
  138. Knorr C, Amrehn C, Seeberger H et al. (1999) Expression of costimulatory molecules in low-grade mucosa-associated lymphoid tissue-type lymphomas in vivo. Am J Pathol 155:2019–2027PubMedCrossRefGoogle Scholar
  139. Knutsen T (1997) Cytogenetic mechanisms in the pathogenesis and progression of follicular lymphoma. Cancer Surv 30:163–192PubMedGoogle Scholar
  140. Konig EA, Kusser WC, Day C et al. (2000) p53 mutations in hairy cell leukemia. Leukemia 14:706–711PubMedCrossRefGoogle Scholar
  141. Korsmeyer SJ (1992) BCL2: an antidote to programmed cell death. Cancer Surv 15:105–118PubMedGoogle Scholar
  142. Lai R, Weiss LM (1998) Hepatitis C virus and non-Hodgkin’s lymphoma. Am J Clin Pathol 109:508–510PubMedGoogle Scholar
  143. Lai JL, Zandecki M, Mary JY et al. (1995) Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood 85:2490–2497PubMedGoogle Scholar
  144. Lampert IA, Thompson I (1988) The spleen in lymphocytic leukemia and related disorders. In: Polliack AD, Catovsky D (eds) Chronic lymphocytic leukemia. Harwood Academic Publishers, New York, pp 193–208Google Scholar
  145. Lardelli P, Bookman MA, Sundeen J, Longo DL, Jaffe ES (1990) Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlations. Am J Surg Pathol 14:752–763PubMedCrossRefGoogle Scholar
  146. Lee JT, Innes DJ Jr, Williams ME (1989) Sequential BCL2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin’s lymphoma. J Clin Invest 84:1454–1459PubMedCrossRefGoogle Scholar
  147. Lennert K (1978) Malignant lymphomas other than Hodgkin’s disease. Springer, Berlin Heidelberg New York, p 281Google Scholar
  148. Lennert K, Feller AC (1990) Histopathology of Non-Hodgkin’s lymphoma (based on the updated Kiel classification). Springer, Berlin Heidelberg New YorkGoogle Scholar
  149. Lennert K, Mohri N, Stein H (1975) The histopathology of malignant lymphoma. Br J Haematol [Suppl] 31:193–203CrossRefGoogle Scholar
  150. Lennert K, Tamm I, Wacker H-H (1991) Histopathology and immunocytochemistry of lymph node biopsies in chronic lymphocytic leukemia and immunocytoma. Leuk Lymphoma [Suppl] 157Google Scholar
  151. Leroux D, Le Marc’Hadour F, Gressin R et al. (1991) Non-Hodgkin’s lymphomas with t(11;14)(q13;q32): a subset of mantle zone/intermediate lymphocytic lymphoma? Br J Haematol 77:346–353PubMedCrossRefGoogle Scholar
  152. Li JY, Gaillard F, Moreau A et al. (1999) Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization. Am J Pathol 154:1449–1452PubMedCrossRefGoogle Scholar
  153. Limpens J, Jong D de, Krieken JH van et al. (1991) BCL2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 6:2271–2276PubMedGoogle Scholar
  154. Lloret E, Mollejo M, Mateo MS et al. (1999) Splenic marginal zone lymphoma with increased number of blasts: an aggressive variant? Hum Pathol 30:1153–1160PubMedCrossRefGoogle Scholar
  155. Lo Coco F, Gaidano G, Louie DC, Offit K, Chaganti RS, Dalla-Favera R (1993) p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 82:2289–2295PubMedGoogle Scholar
  156. Louie DC, Offit K, Jaslow R et al. (1995) p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32). Blood 86:2892–2899PubMedGoogle Scholar
  157. Lovec H, Grzeschiczek A, Kowalski MB, Moroy T (1994) Cyclin D1/BCL1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J 13:3487–3495PubMedGoogle Scholar
  158. Lukes RJ, Collins RD (1974) Immunologic characterization of human malignant lymphomas. Cancer 34:suppl:1488–1503Google Scholar
  159. Machii T, Kitani T (1984) Similarities between IgG-bearing lymphocytes and hairy cells: cytologic and cytochemical studies. Blood 64:166–172PubMedGoogle Scholar
  160. Manconi R, Poletti A, Volpe R, Sulfaro S, Carbone A (1988) Dendritic reticulum cell pattern as a microenvironmental indicator for a distinct origin of lymphoma of follicular mantle cells. Br J Haematol 68:213–218PubMedCrossRefGoogle Scholar
  161. Martinez-Delgado B, Fernandez-Piqueras J, Garcia MJ et al. (1997) Hypermethylation of a 5’ CpG island of p16 is a frequent event in non-Hodgkin’s lymphoma. Leukemia 11:425–428PubMedCrossRefGoogle Scholar
  162. Mateo M, Mollejo M, Villuendas R et al. (1999) 7q31–32 allelic loss is a frequent finding in splenic marginal zone lymphoma. Am J Pathol 154:1583–1589PubMedCrossRefGoogle Scholar
  163. Matolcsy A, Nagy M, Kisfaludy N, Kelenyi G (1999) Distinct clonal origin of low-grade MALT-type and high-grade lesions of a multifocal gastric lymphoma. Histopathology 34:6–8PubMedCrossRefGoogle Scholar
  164. Matutes E, Owusu-Ankomah K, Morilla R et al. (1994) The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 8:1640–1645PubMedGoogle Scholar
  165. McDonnell TJ, Korsmeyer SJ (1991) Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature 349:254–256PubMedCrossRefGoogle Scholar
  166. McDonnell TJ, Deane N, Piatt FM et al. (1989) BCL2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57:79–88PubMedCrossRefGoogle Scholar
  167. Melo JV, Catovsky D, Galton DA (1986) The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group. Br J Haematol 63:377–387PubMedCrossRefGoogle Scholar
  168. Melo JV, Hegde U, Parreira A, Thompson I, Lampert IA, Catovsky D (1987) Splenic B cell lymphoma with circulating villous lymphocytes: differential diagnosis of B cell leukaemias with large spleens. J Clin Pathol 40:642–651PubMedCrossRefGoogle Scholar
  169. Metter GE, Nathwani BN, Burke JS et al. (1985) Morphological subclassification of follicular lymphoma: variability of diagnoses among hematopathologists, a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical Studies. J Clin Oncol 3:25–38PubMedGoogle Scholar
  170. Meusers P, Engelhard M, Bartels H et al. (1989) Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: anthracycline does not improve the prognosis. Hematol Oncol 7:365–380PubMedCrossRefGoogle Scholar
  171. Meusers P, Hense J, Rittinger G (1997) Mantle cell lymphoma: diagnostic criteria, clinical aspects and therapeutic problems. Leukemia [Suppl 2] 11:S60–64PubMedGoogle Scholar
  172. Miranda RN, Cousar JB, Hammer RD, Collins RD, Vnencak-Jones CL (1999) Somatic mutation analysis of IgH variable regions reveals that tumor cells of most parafollicular (monocytoid) B-cell lymphoma, splenic marginal zone B-cell lymphoma, and some hairy cell leukemia are composed of memory B lymphocytes. Hum Pathol 30:306–312PubMedCrossRefGoogle Scholar
  173. Mitelman F (1994) Catalogue of chromosome aberration in cancer. Chromosome 1–12. Wiley-Liss, New YorkGoogle Scholar
  174. Mittrucker HW, Matsuyama T, Grossman A et al. (1997) Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275:540–543PubMedCrossRefGoogle Scholar
  175. Mollejo M, Lloret E, Menarguez J, Piris MA, Isaacson PG (1997) Lymph node involvement by splenic marginal zone lymphoma: morphological and immunohistochemical features. Am J Surg Pathol 21:772–780PubMedCrossRefGoogle Scholar
  176. Moller P, Mielke B, Moldenhauer G (1990) Monoclonal antibody HML-1, a marker for intraepithelial T cells and lymphomas derived thereof, also recognizes hairy cell leukemia and some B-cell lymphomas. Am J Pathol 136:509–512PubMedGoogle Scholar
  177. Monni O, Oinonen R, Elonen E et al. (1998) Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma. Genes Chromosomes Cancer 21:298–307PubMedCrossRefGoogle Scholar
  178. Montalban C, Manzanal A, Castrillo JM, Escribano L, Bellas C (1995) Low grade gastric B-cell MALT lymphoma progressing into high grade lymphoma. Clonal identity of the two stages of the tumour, unusual bone involvement and leukemic dissemination. Histopathology 27:89–91PubMedCrossRefGoogle Scholar
  179. Motokura T, Bloom T, Kim HG et al. (1991) A novel cyclin encoded by a bell-linked candidate oncogene. Nature 350:512–515PubMedCrossRefGoogle Scholar
  180. Muller-Hermelink HK, Greiner A (1998) Molecular analysis of human immunoglobulin heavy chain variable genes (IgVH) in normal and malignant B cells. Am J Pathol 153:1341–1346PubMedCrossRefGoogle Scholar
  181. Muller-Hermelink HK, Ott G, Ott M, Greiner A (1995) [Pathology and pathogenesis of extranodal lymphomas in the gastrointestinal tract]. Schweiz Rundsch Med Prax 84:1416–1422Google Scholar
  182. Müller-Hermelink HK, Zettl A, Pfeifer W, Ott G (2001) Review: Pathology of lymphoma progression. Histopathology 38(4):285–306PubMedCrossRefGoogle Scholar
  183. Mulligan SP, Matutes E, Dearden C, Catovsky D (1991) Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases. Br J Haematol 78:206–209PubMedCrossRefGoogle Scholar
  184. Naeim F, Jacobs AD (1985) Bone marrow changes in patients with hairy cell leukemia treated by recombinant alpha 2-interferon. Hum Pathol 16:1200–1205PubMedCrossRefGoogle Scholar
  185. Nanba K, Jaffe ES, Braylan RC, Soban EJ, Berard CW (1977) Alkaline phosphatase-positive malignant lymphoma. A subtype of B-cell lymphomas. Am J Clin Pathol 68:535–542PubMedGoogle Scholar
  186. Nathwani BN, Metter GE, Miller TP et al. (1986) What should be the morphologic criteria for the subdivision of follicular lymphomas? Blood 68:837–845PubMedGoogle Scholar
  187. Nathwani BN, Anderson JR, Armitage JO et al. (1999) Marginal zone B-cell lymphoma: a clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin’s Lymphoma Classification Project. J Clin Oncol 17:2486–2492PubMedGoogle Scholar
  188. Nessling M, Solinas-Toldo S, Lichter P et al. (1999) Genomic imbalances are rare in hairy cell leukemia. Genes Chromosomes Cancer 26:182–183PubMedCrossRefGoogle Scholar
  189. Neubauer A, Thiede C, Morgner A et al. (1997) Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst 89:1350–1355PubMedCrossRefGoogle Scholar
  190. Neumeister P, Hoefler G, Beham-Schmid C et al. (1997) Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas. Gastroenterology 112:1871–1875PubMedCrossRefGoogle Scholar
  191. Ng MH, Chung YF, Lo KW, Wickham NW, Lee JC, Huang DP (1997) Frequent hypermethylation of p16 and p15 genes in multiple myeloma. Blood 89:2500–2506PubMedGoogle Scholar
  192. Ngan BY, Warnke RA, Wilson M, Takagi K, Cleary ML, Dorfman RF (1991) Monocytoid B-cell lymphoma: a study of 36 cases. Hum Pathol 22:409–421PubMedCrossRefGoogle Scholar
  193. O’Briain DS, Kennedy MJ, Daly PA et al. (1989) Multiple lymphomatous polyposis of the gastrointestinal tract. A clinicopathologically distinctive form of non-Hodgkin’s lymphoma of B-cell centrocytic type. Am J Surg Pathol 13:691–699PubMedCrossRefGoogle Scholar
  194. Offit K, Jhanwar SC, Ladanyi M, Filippa DA, Chaganti RS (1991) Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin’s lymphoma: correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment. Genes Chromosomes Cancer 3:189–201PubMedCrossRefGoogle Scholar
  195. Offit K, Parsa NZ, Filippa D, Jhanwar SC, Chaganti RS (1992) t(9;14)(p13;q32) denotes a subset of low-grade non-Hodgkin’s lymphoma with plasmacytoid differentiation. Blood 80:2594–2599PubMedGoogle Scholar
  196. Offit K, Parsa NZ, Jhanwar SC, Filippa D, Wachtel M, Chaganti RS (1993) Clusters of chromosome 9 aberrations are associated with clinico-pathologic subsets of non-Hodgkin’s lymphoma. Genes Chromosomes Cancer 7:1–7PubMedCrossRefGoogle Scholar
  197. Offit K, Louie DC, Parsa NZ, Noy A, Chaganti RS (1995) Del (7)(q32) is associated with a subset of small lymphocytic lymphoma with plasmacytoid features. Blood 86:2365–2370PubMedGoogle Scholar
  198. Ohyashiki K, Ohyashiki JH, Takeuchi J, Han T, Henderson ES, Sandberg AA (1987) Cytogenetic studies in hairy cell leukemia. Cancer Genet Cytogenet 24:109–117PubMedCrossRefGoogle Scholar
  199. Oscier DG, Matutes E, Gardiner A et al. (1993) Cytogenetic studies in splenic lymphoma with villous lymphocytes. Br J Haematol 85:487–491PubMedCrossRefGoogle Scholar
  200. Oscier DG, Gardiner A, Mould S (1996) Structural abnormalities of chromosome 7q in chronic lymphoproliferative disorders. Cancer Genet Cytogenet 92:24–27PubMedCrossRefGoogle Scholar
  201. Ott MM, Ott G, Kuse R et al. (1994) The anaplastic variant of centrocytic lymphoma is marked by frequent rearrangements of the BCL1 gene and high proliferation indices. Histopathology 24:329–334PubMedCrossRefGoogle Scholar
  202. Ott MM, Helbing A, Ott G et al. (1996) BCL1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma. J Pathol 179:238–242PubMedCrossRefGoogle Scholar
  203. Ott MM, Bartkova J, Bartek J et al. (1997a) Cyclin D1 expression in mantle cell lymphoma is accompanied by downregulation of cyclin D3 and is not related to the proliferative activity. Blood 90:3154–3159PubMedGoogle Scholar
  204. Ott G, Kalla J, Ott MM et al. (1997b) Blastoid variants of mantle cell lymphoma: frequent BCL1 rearrangements at the major translocation cluster region and tetraploid chromosome clones. Blood 89:1421–1429PubMedGoogle Scholar
  205. Ott G, Katzenberger T, Greiner A et al. (1997c) The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin’s lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res 57:3944–3948PubMedGoogle Scholar
  206. Ott G, Kalla J, Steinhoff A et al. (1998) Trisomy 3 is not a common feature in malignant lymphomas of mucosa-associated lymphoid tissue type. Am J Pathol 153:689–694PubMedCrossRefGoogle Scholar
  207. Ott MM, Rosenwald A, Katzenberger T et al. (2000) Marginal zone B-cell lymphomas (MZBL) arising at different sites represent different biological entities. Genes Chromosomes Cancer 28:380–386PubMedCrossRefGoogle Scholar
  208. Ott G, Katzenberger T, Lohr A, Kindelberger S, Rudiger T, Wilhelm M, Kalla J, Rosenwald A, Muller JG, Ott MM, Muller-Hermelink HK (2002) Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood 99(10):3806–3812PubMedCrossRefGoogle Scholar
  209. Otter R, Gerrits WB, Sandt MMvan der, Hermans J, Willemze R (1989) Primary extranodal and nodal non-Hodgkin’s lymphoma. A survey of a population-based registry. Eur J Cancer Clin Oncol 25:1203–1210PubMedCrossRefGoogle Scholar
  210. Owens MR, Strauchen JA, Rowe JM, Bennett JM (1984) Prolymphocytic leukemia: histologic findings in atypical cases. Hematol Oncol 2:249–257PubMedGoogle Scholar
  211. Pangalis GA, Nathwani BN, Rappaport H (1980) Detection of cytoplasmic immunologlobulin in well-differentiated lymphoproliferative diseases by the immunoperoxidase method. Cancer 45:1334–1339PubMedCrossRefGoogle Scholar
  212. Patsouris E, Noel H, Lennert K (1990) Lymphoplasmacytic/lymphoplasmacytoid immunocytoma with a high content of epithelioid cells. Histologic and immunohistochemical findings. Am J Surg Pathol 14:660–670PubMedCrossRefGoogle Scholar
  213. Peng H, Chen G, Du M, Singh N, Isaacson PG, Pan L (1996) Replication error phenotype and p53 gene mutation in lymphomas of mucosa-associated lymphoid tissue. Am J Pathol 148:643–648PubMedGoogle Scholar
  214. Peng H, Diss T, Isaacson PG, Pan L (1997) c-myc gene abnormalities in mucosa-associated lymphoid tissue (MALT) lymphomas. J Pathol 181:381–386PubMedCrossRefGoogle Scholar
  215. Peng H, Du M, Diss TC, Isaacson PG, Pan L (1997) Genetic evidence for a clonal link between low and high-grade components in gastric MALT B-cell lymphoma. Histopathology 30:425–429PubMedCrossRefGoogle Scholar
  216. Pezzella F, Gatter KC, Mason DY et al. (1990) BCL2 protein expression in follicular lymphomas in absence of 14;18 translocation. Lancet 336:1510–1511PubMedCrossRefGoogle Scholar
  217. Pileri SA, Sabattini E (1997) A rational approach to immunohistochemical analysis of malignant lymphomas on paraffin wax sections. J Clin Pathol 50:2–4PubMedCrossRefGoogle Scholar
  218. Pinotti G, Zueca E, Roggero E et al. (1997) Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk Lymphoma 26:527–537PubMedGoogle Scholar
  219. Pinyol M, Hernandez L, Cazorla M et al. (1997) Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas. Blood 89:272–280PubMedGoogle Scholar
  220. Pinyol M, Cobo F, Bea S et al. (1998) p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin’s lymphomas. Blood 91:2977–2984PubMedGoogle Scholar
  221. Piris MA, Mollejo M, Campo E, Menarguez J, Flores T, Isaacson PG (1998) A marginal zone pattern may be found in different varieties of non-Hodgkin’s lymphoma: the morphology and immunohistology of splenic involvement by B-cell lymphomas simulating splenic marginal zone lymphoma. Histopathology 33:230–239PubMedCrossRefGoogle Scholar
  222. Pittaluga S, Verhoef G, Criel A et al. (1996) „Small“B-cell non-Hodgkin’s lymphomas with splenomegaly at presentation are either mantle cell lymphoma or marginal zone cell lymphoma. A study based on histology, cytology, immunohistochemistry, and cytogenetic analysis. Am J Surg Pathol 20:211–223PubMedCrossRefGoogle Scholar
  223. Poetsch M, Weber-Matthiesen K, Plendl HJ, Grote W, Schlegelberger B (1996) Detection of the t(14;18) chromosomal translocation by interphase cytogenetics with yeast-artificial-chromosome probes in follicular lymphoma and nonneoplastic lymphoproliferation. J Clin Oncol 14:963–969PubMedGoogle Scholar
  224. Posnett DN, Wang CY, Chiorazzi N, Crow MK, Kunkel HG (1984) An antigen characteristic of hairy cell leukemia cells is expressed on certain activated B cells. J Immunol 133:1635–1640PubMedGoogle Scholar
  225. Qin Y, Greiner A, Trunk MJ, Schmausser B, Ott MM, Muller-Hermelink HK (1995) Somatic hypermutation in lowgrade mucosa-associated lymphoid tissue-type B-cell lymphoma. Blood 86:3528–3534PubMedGoogle Scholar
  226. Quelle DE, Ashmun RA, Shurtleff SA et al. (1993) Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 7:1559–1571PubMedCrossRefGoogle Scholar
  227. Quintanilla-Martinez L, Thieblemont C, Fend F et al. (1998) Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor. Am J Pathol 153:175–182PubMedCrossRefGoogle Scholar
  228. Raffeld M, Jaffe ES (1991) BCL1, t(11;14), and mantle cell-derived lymphomas. Blood 78:259–263PubMedGoogle Scholar
  229. Rappaport HJ, Hicks EB (1954) follicular lymphoma. A reevaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases. Cancer 9:792–821CrossRefGoogle Scholar
  230. Remstein ED, James CD, Kurtin PJ (2000) Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas. Am J Pathol 156:1183–1188PubMedCrossRefGoogle Scholar
  231. Richards MA, Hall PA, Gregory WM et al. (1989) Lymphoplasmacytoid and small cell centrocytic non-Hodgkin’s lymphoma — a retrospective analysis from St Bartholomew’s Hospital 1972–1986. Hematol Oncol 7:19–35PubMedCrossRefGoogle Scholar
  232. Richelda R, Ronchetti D, Baldini L et al. (1997) A novel chromosomal translocation t(4; 14)(p16.3; q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene. Blood 90:4062–4070PubMedGoogle Scholar
  233. Rimokh R, Gadoux M, Bertheas MF et al. (1993) FVT-1, a novel human transcription unit affected by variant translocation t(2;18)(p11;q21) of follicular lymphoma. Blood 81:136–142PubMedGoogle Scholar
  234. Rimokh R, Berger F, Delsol G et al. (1994) Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood 83:1871–1875PubMedGoogle Scholar
  235. Robinson DS, Posnett DN, Zola H, Catovsky D (1985) Normal counterparts of hairy cells and B-prolymphocytes in the peripheral blood. An ultrastructural study with monoclonal antibodies and the immunogold method. Leuk Res 9:335–348PubMedCrossRefGoogle Scholar
  236. Rosenberg CL, Wong E, Petty EM et al. (1991) PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci USA 88:9638–9642PubMedCrossRefGoogle Scholar
  237. Rosenwald A, Ott G, Stilgenbauer S et al. (1999) Exclusive detection of the t(11;18)(q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas. Am J Pathol 155:1817–1821PubMedCrossRefGoogle Scholar
  238. Rothe M, Pan MG, Henzel WJ, Ayres TM, Goeddel DV (1995) The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83:1243–1252PubMedCrossRefGoogle Scholar
  239. Salmon SE, Cassady JR (1988) In: DeVita VT, Hellman S, Rosenberg S (eds) Cancer, principles and practice of oncology. Lippincott, Philadelphia, p 1854Google Scholar
  240. Sanchez-Beato M, Saez AI, Martinez-Montero JC et al. (1997) Cyclin-dependent kinase inhibitor p27KIP1 in lymphoid tissue: p27KIP1 expression is inversely proportional to the proliferative index. Am J Pathol 151:151–160PubMedGoogle Scholar
  241. Sander CA, Yano T, Clark HM et al. (1993) p53 mutation is associated with progression in follicular lymphomas. Blood 82:1994–2004PubMedGoogle Scholar
  242. Savio A, Franzin G, Wotherspoon AC et al. (1996) Diagnosis and posttreatment follow-up of Helicobacter pylori-ipositive gastric lymphoma of mucosa-associated lymphoid tissue: histology, polymerase chain reaction, or both? Blood 87:1255–1260PubMedGoogle Scholar
  243. Schaffner C, Idler I, Stilgenbauer S, Dohner H, Lichter P (2000) Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proc Natl Acad Sci USA 97:2773–2778PubMedCrossRefGoogle Scholar
  244. Schmid C, Kirkham N, Diss T, Isaacson PG (1992) Splenic marginal zone cell lymphoma. Am J Surg Pathol 16:455–466PubMedCrossRefGoogle Scholar
  245. Schrek R, Donnelly WJ (1966) „Hairy” cells in blood in lymphoreticular neoplastic disease and „flagellated“cells of normal lymph nodes. Blood 27:199–211PubMedGoogle Scholar
  246. Schwarze MM, Hawley RG (1995) Prevention of myeloma cell apoptosis by ectopic BCL2 expression or interleukin 6-mediated up-regulation of bcl-xL. Cancer Res 55:2262–2265PubMedGoogle Scholar
  247. Siebert R, Gesk S, Harder S et al. (1998) Deletions in the long arm of chromosome 10 in lymphomas with t(14;18): a pathogenetic role of the tumor suppressor genes PTEN/MMAC1 and MXI1? Blood 92:4487–4489PubMedGoogle Scholar
  248. Spriano P, Barosi G, Invernizzi R et al. (1986) Splenomegalic immunocytoma with circulating hairy cells. Report of eight cases and revision of the literature. Haematologica 71:25–33PubMedGoogle Scholar
  249. Stec I, Wright TJ, Ommen GJ van et al. (1998) WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma [published erratum appears in Hum Mol Genet 1998 Sep;7(9):1527]. Hum Mol Genet 7:1071–1082PubMedCrossRefGoogle Scholar
  250. Stein H, Lennert K, Feller AC, Mason DY (1984) Immunohistological analysis of human lymphoma: correlation of histological and immunological categories. Adv Cancer Res 42:67–147PubMedCrossRefGoogle Scholar
  251. Steinbach G, Ford R, Glober G et al. (1999) Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med 131:88–95PubMedGoogle Scholar
  252. Stilgenbauer S, Leupolt E, Ohl S et al. (1995) Heterogeneity of deletions involving RB-1 and the D13S25 locus in B-cell chronic lymphocytic leukemia revealed by fluorescence in situ hybridization. Cancer Res 55:3475–3477PubMedGoogle Scholar
  253. Stilgenbauer S, Winkler D, Ott G et al. (1999) Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma. Blood 94:3262–3264PubMedGoogle Scholar
  254. Stone RM (1990) Prolymphocytic leukemia. Hematol Oncol Clin North Am 4:457–471PubMedGoogle Scholar
  255. Symmers D (1927) Follicular lymphadenopathy with splenomegaly. A newly recognized disease of the lymphatic system. Arch Pathol 3:816–820Google Scholar
  256. Takimoto Y, Takafuta T, Imanaka F, Kuramoto A, Sasaki N, Nanba K (1996) Histological progression of follicular lymphoma associated with p53 mutation and rearrangement of the C-MYC gene. Hiroshima J Med Sci 45:69–73PubMedGoogle Scholar
  257. Thangavelu M, Olopade O, Beckman E et al. (1990) Clinical, morphologic, and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18)(q32;q21) and t(8;14)(q24;q32) or t(8;22)(q24;q11). Genes Chromosomes Cancer 2:147–158PubMedCrossRefGoogle Scholar
  258. The Non-Hodgkin’s Lymphoma Classification Project (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. Blood 89:3909–3918Google Scholar
  259. Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281:1312–1316PubMedCrossRefGoogle Scholar
  260. Tierens A, Delabie J, Pittaluga S, Driessen A, DeWolf-Peeters C (1998) Mutation analysis of the rearranged immunoglobulin heavy chain genes of marginal zone cell lymphomas indicates an origin from different marginal zone B lymphocyte subsets. Blood 91:2381–2386PubMedGoogle Scholar
  261. Tilly H, Rossi A, Stamatoullas A et al. (1994) Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood 84:1043–1049PubMedGoogle Scholar
  262. Tolksdorf G, Stein H, Lennert K (1980) Morphological and immunological definition of a malignant lymphoma derived from germinal-centre cells with cleaved nuclei (centrocytes). Br J Cancer 41:168–182PubMedCrossRefGoogle Scholar
  263. Troussard X, Mauvieux L, Radford-Weiss I et al. (1998) Genetic analysis of splenic lymphoma with villous lymphocytes: a Groupe Francais d’Hematologie Cellulaire (GFHC) study. Br J Haematol 101:712–721PubMedCrossRefGoogle Scholar
  264. Tsujimoto Y, Yunis J, Onorato-Showe L, Erikson J, Nowell PC, Croce CM (1984) Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science 224:1403–1406PubMedCrossRefGoogle Scholar
  265. Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce CM (1985) The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229:1390–1393PubMedCrossRefGoogle Scholar
  266. Turner A, Kjeldsberg CR (1978) Hairy cell leukemia: a review. Medicine (Baltimore) 57:477–499Google Scholar
  267. Tycko B, Sklar J (1990) Chromosomal translocations in lymphoid neoplasia: a reappraisal of the recombinase model. Cancer Cells 2:1–8PubMedGoogle Scholar
  268. Ueshima Y, Alimena G, Rowley JD, Golomb HM (1983) Cytogenetic studies in patients with hairy cell leukemia. Hematol Oncol 1:215–226PubMedCrossRefGoogle Scholar
  269. Urashima M, Teoh G, Ogata A et al. (1997) Characterization of p16(INK4A) expression in multiple myeloma and plasma cell leukemia. Clin Cancer Res 3:2173–2179PubMedGoogle Scholar
  270. Vaandrager JW, Schuuring E, Philippo K, Kluin PM (2000) V(D)J recombinase-mediated transposition of the BCL2 gene to the IGH locus in follicular lymphoma. Blood 96:1947–1952PubMedGoogle Scholar
  271. Vandenberghe E, De Wolf-Peeters C, Oord van den et al. (1991) Translocation (11;14): a cytogenetic anomaly associated with B-cell lymphomas of non-follicle centre cell lineage. J Pathol 163:13–18PubMedCrossRefGoogle Scholar
  272. Van den Oord JJ, Wolf-Peeters C de, Desmet VJ (1985) Hairy cell leukemia: a B-lymphocytic disorder derived from splenic marginal zone lymphocytes? Blut 50:191–194PubMedCrossRefGoogle Scholar
  273. Van Krieken JH, Raffeld M, Raghoebier S, Jaffe ES, Ommen G J van, Kluin PM (1990) Molecular genetics of gastrointestinal non-Hodgkin’s lymphomas: unusual prevalence and pattern of c-myc rearrangements in aggressive lymphomas. Blood 76:797–800PubMedGoogle Scholar
  274. Vasef MA, Medeiros LJ, Yospur LS, Sun NC, McCourty A, Brynes RK (1997) Cyclin D1 protein in multiple myeloma and plasmacytoma: an immunohistochemical study using fixed, paraffin-embedded tissue sections. Mod Pathol 10:927–932PubMedGoogle Scholar
  275. Villuendas R, Pezzella F, Gatter K et al. (1997) p21WAF1/CIP1 and MDM 2 expression in non-Hodgkin’s lymphoma and their relationship to p53 status: a p53+, MDM 2-, p21-immunophenotype associated with missense p53 mutations. J Pathol 181:51–61PubMedCrossRefGoogle Scholar
  276. Villuendas R, Sanchez-Beato M, Martinez JC et al. (1998) Loss of p16/INK4A protein expression in non-Hodgkin’s lymphomas is a frequent finding associated with tumor progression. Am J Pathol 153:887–897PubMedCrossRefGoogle Scholar
  277. Wakatsuki Y, Neurath MF, Max EE, Strober W (1994) The B cell-specific transcription factor BSAP regulates B cell proliferation. J Exp Med 179:1099–1108PubMedCrossRefGoogle Scholar
  278. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81:323–330PubMedCrossRefGoogle Scholar
  279. Williams ME, Meeker TC, Swerdlow SH (1991) Rearrangement of the chromosome 11 BCL1 locus in centrocytic lymphoma: analysis with multiple breakpoint probes. Blood 78:493–498PubMedGoogle Scholar
  280. Willis TG, Yer MJ (2000) The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood 96:808–822PubMedGoogle Scholar
  281. Willis TG, Jadayel DM, Du MQ et al. (1999) Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 96:35–45PubMedCrossRefGoogle Scholar
  282. Wiltshaw E (1976) The natural history of extramedullary plasmacytoma and its relation to solitary myeloma of bone and myelomatosis. Medicine (Baltimore) 55:217–238CrossRefGoogle Scholar
  283. Withers DA, Harvey RC, Faust JB, Melnyk O, Carey K, Meeker TC (1991) Characterization of a candidate BCL1 gene. Mol Cell Biol 11:4846–4853PubMedGoogle Scholar
  284. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG (1991) Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338:1175–1176PubMedCrossRefGoogle Scholar
  285. Wotherspoon AC, Doglioni C, Isaacson PG (1992) Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT): a multifocal disease. Histopathology 20:29–34PubMedCrossRefGoogle Scholar
  286. Wotherspoon AC, Doglioni C, Diss TC et al. (1993) Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342:575–577PubMedCrossRefGoogle Scholar
  287. Wotherspoon AC, Finn TM, Isaacson PG (1995) Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue. Blood 85:2000–2004PubMedGoogle Scholar
  288. Wu CD, Jackson CL, Medeiros LJ (1996) Splenic marginal zone cell lymphoma. An immunophenotypic and molecular study of five cases. Am J Clin Pathol 105:277–285PubMedGoogle Scholar
  289. Xu WS, Chan AC, Liang R, Srivastava G (1998) No evidence of replication error phenotype in primary gastric lymphoma of mucosa-associated lymphoid tissue. Int J Cancer 76:635–638PubMedCrossRefGoogle Scholar
  290. Yam LT, Janckila AJ, Li CY, Lam WK (1987) Cytochemistry of tartrate-resistant acid phosphatase: 15 years’ experience. Leukemia 1:285–288PubMedGoogle Scholar
  291. Ye H, Dogan A, Karran L et al. (2000) BCL10 expression in normal and neoplastic lymphoid tissue: nuclear localization in MALT lymphoma. Am J Pathol 157:1147–1154PubMedCrossRefGoogle Scholar
  292. Yoshida S, Nakazawa N, Iida S et al. (1999) Detection of MUM1/IRF4-IgH fusion in multiple myeloma. Leukemia 13:1812–1816PubMedCrossRefGoogle Scholar
  293. Zhang Y, Matthiesen P, Harder S et al. (2000) A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization. Genes Chromosomes Cancer 27:52–58PubMedCrossRefGoogle Scholar
  294. Zojer N, Konigsberg R, Ackermann J et al. (2000) Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization. Multicenter Investigation of Bone Marrow Transplantation for Sickle Cell Disease. Blood 95:1925–1930PubMedGoogle Scholar
  295. Zucker-Franklin D (1985) The pathology in multiple myeloma and related disorders. In: Wiernik P, Cannellos R, Kyle C (eds) Neoplastic disease of the blood. Churchill Livingstone, New York, p 462Google Scholar
  296. Zukerberg LR, Medeiros LJ, Ferry JA, Harris NL (1993) Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features. Am J Clin Pathol 100:373–385PubMedGoogle Scholar
  297. Zukerberg LR, Yang WI, Arnold A, Harris NL (1995) Cyclin D1 expression in non-Hodgkin’s lymphomas. Detection by immunohistochemistry. Am J Clin Pathol 103:756–760PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • Hans Konrad Müller-Hermelink
  • German Ott

There are no affiliations available

Personalised recommendations